Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Gastrointestinal carcinoma
ADR ID BADD_A01756
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.04      Gastrointestinal neoplasms malignant NEC
16.13.04.001      Gastrointestinal carcinoma
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.03      Malignant miscellaneous gastrointestinal neoplasms
07.21.03.001      Gastrointestinal carcinoma
Description Not Available
MedDRA Code 10017940
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Carcinoma gastrointestinal | Carcinoma intestinal | Gastrointestinal carcinoma | Gastrointestinal neoplasm malignant | Gastrointestinal tract cancer NOS | GI neoplasm malignant | Intestinal carcinoma | Malignant neoplasm of ill-defined sites within the digestive organs and peritoneum | Malignant neoplasm of intestinal tract, part unspecified | Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneum | Malignant neoplasm of other sites of digestive system and intra-abdominal organs | Malignant neoplasm of other sites within the digestive organs and peritoneum | Bowel cancer
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02165Teriflunomide0.000362%
BADD_D02241Tolcapone--
BADD_D02257Trametinib0.000336%
BADD_D02331Valsartan0.000079%
BADD_D02345Venetoclax0.000168%
BADD_D02352Verteporfin--
BADD_D02365Vismodegib0.000112%
BADD_D02373Warfarin0.000042%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02393Zolmitriptan--
BADD_D02412Octreotide0.000186%
BADD_D02464Fingolimod0.001447%
BADD_D02473Sodium chloride--
The 2th Page    First    Pre   2    Total 2 Pages